Jeena Sikho Lifecare Announces 9th AGM on Sep 28, 2026, Releases FY26 Annual Report
Jeena Sikho Lifecare will hold its 9th AGM on September 28, 2026. The company released its FY26 Integrated Annual Report, proposing a final dividend of ₹4.50 per equity share. Key agenda items include adopting FY26 financial statements and reappointing/appointing directors.
The AGM and dividend announcement are significant for shareholders as they involve decisions on company governance and profit distribution. The release of the annual report provides crucial financial and operational insights.
The announcement is a routine corporate event (AGM) and the release of the annual report, which are standard procedures. While a dividend is proposed, there are no immediate financial results or major strategic shifts highlighted that would strongly influence sentiment.
Jeena Sikho Lifecare Limited has announced that its 9th Annual General Meeting (AGM) will be held on Monday, September 28, 2026, at 12:00 Noon. The meeting will take place at First Floor, Parle G Godown, City Enclave, Back Side JP Hospital, Near Anand Complex, Zirakpur, Main Road, SAS Nagar, Punjab 140603.
In conjunction with the AGM, the company has also released its Integrated Annual Report for the Financial Year 2025-26. Both the Notice of the 9th AGM and the Annual Report have been dispatched electronically to shareholders. Physical copies are available upon request, and the documents are also accessible on the company's website and the NSDL e-voting portal.
The AGM agenda includes the consideration and adoption of the Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2026. A final dividend of ₹4.50 per equity share of face value ₹2 has been proposed for the financial year ended March 31, 2026. The meeting will also address the reappointment of directors, including Mrs. Bhavna Grover, Mr. Karan Vir Bindra, Mr. Manish Grover, and the appointment of new directors Mr. Ajay Sharma, Mrs. Sapna Singh, Dr. Ish Sharma, and Mr. Ankush Kaushal. Additionally, approvals for granting loans, guarantees, and making investments under Sections 185 and 186 of the Companies Act, 2013, will be sought.
What to do with a filing like this
Jeena Sikho Lifecare Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Jeena Sikho Lifecare Limited. Read the original for the full detail.